BioCryst Pharmaceuticals ($BCRX)

Description

Develops oral small-molecule and injectable protein medicines for hereditary angioedema and other rare diseases, with physician-requested investigational access in eligible cases.

BioCryst Pharmaceuticals ($BCRX) is located in the Research Triangle ecosystem.

Related

• Liquidia ($LQDA)Develops therapies and lung drug-delivery technology for rare cardiopulmonary diseases, including pulmonary arterial hypertension,…
• Karyopharm Therapeutics ($KPTI)Develops and investigates oral nuclear export inhibitor cancer therapies for patients with cancer, especially in disease areas with high…
• bluebird bioDevelops one-time gene addition treatments for rare hematologic diseases, using patients' own cells and patient support services to help…
• Krystal Biotech ($KRYS)Develops and delivers redosable genetic medicines, including VYJUVEK for dystrophic epidermolysis bullosa, using engineered HSV-1 vectors…
• Beam Therapeutics ($BEAM)Develops investigational base-editing genetic medicines and delivery technologies, including electroporation, nonviral, and viral methods,…
• Ionis Pharmaceuticals ($IONS)Develops RNA- and DNA-targeted medicines for people with serious diseases, with marketed therapies including TEGSEDI and WAYLIVRA for…
• Genesis TherapeuticsBuilds molecular AI models and a design platform to optimize small-molecule drug discovery and create new medicines for partners and…
• Locus BiosciencesDevelops bacteriophage-based precision medicines and microbiome biotherapeutics to target disease-causing bacteria in infections, with…
• Humacyte ($HUMA)Develops and manufactures bioengineered human tissues and organs intended as off-the-shelf regenerative implants, with investigational…
• ProfluentBuilds AI systems that design proteins from natural scaffolds or from scratch for therapeutic, industrial enzyme, and other protein design…
• CRISPR Therapeutics ($CRSP)CRISPR Therapeutics develops CRISPR-based gene-editing therapies across hemoglobinopathies, oncology, diabetes, and cardiovascular disease,…
• Numerion LabsBuilds an AI platform that searches chemical space for novel drug-like molecules, supporting small-molecule drug discovery programs for…